Anti-DLL4 & VEGF Reference Antibody (Navicixizumab)

Produktübersicht

• Artikelname: Anti-DLL4 & VEGF Reference Antibody (Navicixizumab)
• Artikelnummer: SYB-CHBA058
• Hersteller Artikelnummer: CHBA058
• Alternativnummer: SYB-CHBA058-100UG, SYB-CHBA058-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-CD3 & BCMA Reference Antibody (Teclistamab) (CHB454) is expressed from CHO, with a configuration of DuoBody. The heavy chain type is IgG4-SPFALA, and the light chain type is lambda.It has a predicted MW of 143.64 kDa.

Produkteigenschaften

• Konzentration: 1mg/ml
• UniProt: Q9NR61
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: DLL4,VEGF